Great RESEARCH GETS great RESULTS
Although scientific publishing metrics commonly used present many shortcomings, these metrics are currently the only objective and internationally recognized way of assessing scientific production. These metrics rank IRCCS Ospedale San Raffaele as one of the leading biomedical research institute in Italy and Europe.
In 2021 alone researchers working in the institute published 2306 papers, with a mean impact factor of 6,8 and a total impact factor of 15.626.
These numbers have steadily grown during the years. Behind them, there is the daily commitment of our researchers and a remarkable investment in human and technological resources by the institute.
Ospedale San Raffaele is at the forefront of biomedical innovation thanks not only to its basic research activity, but also to the development and testing of new therapies.
Its commitment to the improvement of clinical practice is proven by more than 500 ongoing multicenters clinical trials and by more than 450 new study proposals submitted to the institutional review board of IRCCS Ospedale San Raffaele every year. These numbers have steadily grown during the years thanks to the support provided by the Clinical Trial Center of the institute.
A HISTORY of scientific breakthroughs
Beside numbers and metrics, the scientific output of Ospedale San Raffaele is best described by its impact on clinical practice. In 50 years of research history, the institute has brought to doctors and patients innovative therapies and procedures that have changed the treatment protocols of many disabling diseases.